PPD has extensive experience in planning and implementing Phase I-IV programs for urology studies across multiple countries and sites. In the past five years, we have conducted or supported over 220 protocols in urologic indications involving more than 46,000 patients at approximately 7,100 sites.
Our global investigator network includes more than 9,515 urologists, nephrologists, internists and obstetricians/gynecologists. Close working relationships with these investigators and sites ensure our ability to conduct a preliminary feasibility assessment quickly in order to predict enrollment and identify potential challenges for a viable protocol.
Urology Clinical Trial Experience
With global experience across multiple urology indications, we have conducted trials in recent years in the following:
- Benign Prostatic Hyperplasia (BPH) / Lower Urinary Tract Symptoms (LUTS)
- Erectile dysfunction
- Kidney/renal disease
- Overactive bladder
- Premature ejaculation